The Latest Breaking News from FDA

While the U.S. Food and Drug Administration (FDA) and the officials from the CDC continue to investigate the risks, the current recommendation is to continue the vaccine as "the estimated benefits of RSV vaccination continued to outweigh potential risks."

Vapes with candy-like flavors such as “blue razz ice” and “pink lemonade” dominated the study.

Before the new oral medication, women experiencing postnatal depression were prescribed an intravenous injection which risks excessive sedation and a sudden loss of consciousness.

The tool, from telehealth company Ro, lets users report when they find the drug in stock and when there’s a shortage.

As Intuitive Surgical gets FDA clearance for its next-gen robotic surgery system, ISRG stock teases a new breakout.

Government lawyers had told the court flights could go in late June – but then Rishi Sunak called the election

Helpful tool or harmful fad?

The pharma sector is primed for solid growth owing to technological advancements, growing healthcare needs, and a rise in chronic diseases. Given this backdrop, let’s analyze the fundamentals of pharmaceutical stocks Pfizer (PFE) and Bristol-Myers Squibb (BMY) to determine which of these stocks offer better dividend stability and growth. Read…

“The singular most effective and consistent way of extending lifespan in animals is caloric restriction.”

Guardant Health stock jumped Friday after an FDA panel recommended the agency approval Guardant's blood-based colon cancer screening test.

The first paralysed man with a Neuralink chip reports success (racing games!), but software updates and brain response pose challenges.